U.S Physical Therapy Revenue 2010-2024 | USPH

U.S Physical Therapy revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
U.S Physical Therapy Annual Revenue
(Millions of US $)
2023 $605
2022 $553
2021 $495
2020 $423
2019 $482
2018 $454
2017 $414
2016 $357
2015 $331
2014 $305
2013 $264
2012 $250
2011 $232
2010 $211
2009 $201
U.S Physical Therapy Quarterly Revenue
(Millions of US $)
2024-03-31 $156
2023-12-31 $155
2023-09-30 $150
2023-06-30 $151
2023-03-31 $149
2022-12-31 $141
2022-09-30 $140
2022-06-30 $141
2022-03-31 $132
2021-12-31 $130
2021-09-30 $126
2021-06-30 $127
2021-03-31 $112
2020-12-31 $117
2020-09-30 $109
2020-06-30 $84
2020-03-31 $113
2019-12-31 $122
2019-09-30 $117
2019-06-30 $126
2019-03-31 $116
2018-12-31 $117
2018-09-30 $113
2018-06-30 $115
2018-03-31 $108
2017-12-31 $109
2017-09-30 $103
2017-06-30 $104
2017-03-31 $98
2016-12-31 $91
2016-09-30 $88
2016-06-30 $90
2016-03-31 $87
2015-12-31 $87
2015-09-30 $84
2015-06-30 $83
2015-03-31 $77
2014-12-31 $79
2014-09-30 $78
2014-06-30 $78
2014-03-31 $70
2013-12-31 $69
2013-09-30 $66
2013-06-30 $67
2013-03-31 $63
2012-12-31 $61
2012-09-30 $62
2012-06-30 $64
2012-03-31 $63
2011-12-31 $55
2011-09-30 $60
2011-06-30 $60
2011-03-31 $57
2010-12-31 $53
2010-09-30 $53
2010-06-30 $54
2010-03-31 $50
2009-12-31 $50
2009-09-30 $51
2009-06-30 $52
2009-03-31 $48
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.388B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 0.00
Quest Diagnostics (DGX) United States $15.437B 15.95
DaVita (DVA) United States $12.399B 15.40
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00